Bolt Biotherapeutics, Inc.

BOLT ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $227.8M

Liabilities Breakdown FY2022

Total Liabilities: $56.3M